Low levels of TFF2 supported the best discrimination between nondysplastic Barrett’s esophagus and Barrett’s esophagus with cancer, followed by high levels of DCLK1, low goblet ratio and high LGR5 expression [92]. This evidence concerns the gene DCLK1 and Barrett esophagus.